These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6768212)
1. NADH-cytochrome b5 reductase in platelets and leukocytes with special reference to normal levels and to levels in carriers of hereditary methemoglobinemia with or without neurological symptoms. Tanishima K; Matsuki T; Fukuda N; Takeshita M; Yoneyama Y Acta Haematol; 1980; 63(1):7-12. PubMed ID: 6768212 [TBL] [Abstract][Full Text] [Related]
2. Alteration of NADH-diaphorase and cytochrome b5 reductase activities of erythrocytes, platelets, and leucocytes in hereditary methaemoglobinaemia with and without mental retardation. Takeshita M; Matsuki T; Tanishima K; Yubisui T; Yoneyama Y; Kurata K; Hara N; Igarashi T J Med Genet; 1982 Jun; 19(3):204-9. PubMed ID: 6896729 [TBL] [Abstract][Full Text] [Related]
3. [Hereditary methemoglobinemia due to NADH cytochrome b5 abnormality--clinical importance of the enzyme in leukocytes and platelets]. Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Meguro T; Yamada K; Fujii H; Takizawa T; Miwa S Rinsho Ketsueki; 1986 Mar; 27(3):412-9. PubMed ID: 3735692 [No Abstract] [Full Text] [Related]
4. [Clinical significance of cytochrome b5 reductase analysis in blood cell chemical tests]. Takeshita M Nihon Rinsho; 1989 Dec; 48 Suppl():982-4. PubMed ID: 2622040 [No Abstract] [Full Text] [Related]
5. New variant of cytochrome b5 reductase deficiency (b5RKurashiki) in red cells, platelets, lymphocytes, and cultured fibroblasts with congenital methemoglobinemia, mental and neurological retardation, and skeletal anomalies. Yawata Y; Ding L; Tanishima K; Tomoda A Am J Hematol; 1992 Aug; 40(4):299-305. PubMed ID: 1503085 [TBL] [Abstract][Full Text] [Related]
8. Hereditary methemoglobinemia due to cytochrome b5 reductase deficiency in blood cells without associated neurologic and mental disorders. Tanishima K; Tanimoto K; Tomoda A; Mawatari K; Matsukawa S; Yoneyama Y; Ohkuwa H; Takazakura E Blood; 1985 Dec; 66(6):1288-91. PubMed ID: 4063522 [TBL] [Abstract][Full Text] [Related]
9. Decrease of palmitoyl-CoA elongation in platelets and leukocytes in the patient of hereditary methemoglobinemia associated with mental retardation. Takeshita M; Tamura M; Kugi M; Matsuki T; Yoneyama Y; Igarashi T Biochem Biophys Res Commun; 1987 Oct; 148(1):384-91. PubMed ID: 3675585 [TBL] [Abstract][Full Text] [Related]
10. Analysis of mutant NADH-cytochrome b5 reductase: apparent "type III" methemoglobinemia can be explained as type I with an unstable reductase. Nagai T; Shirabe K; Yubisui T; Takeshita M Blood; 1993 Feb; 81(3):808-14. PubMed ID: 8427971 [TBL] [Abstract][Full Text] [Related]
14. Enzymopenic hereditary methemoglobinemia: a clinical/biochemical classification. Jaffé ER Blood Cells; 1986; 12(1):81-90. PubMed ID: 3539237 [TBL] [Abstract][Full Text] [Related]
15. Structural analysis of NADH-cytochrome b5 reductase in relation to hereditary methemoglobinemia. Yubisui T; Murakami K; Shirabe K; Takeshita M; Zenno S; Tomatsu S; Fukumaki Y Prog Clin Biol Res; 1989; 319():107-19; discussion 120-1. PubMed ID: 2695933 [No Abstract] [Full Text] [Related]
16. Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay. Borgese N; Pietrini G; Gaetani S J Clin Invest; 1987 Nov; 80(5):1296-302. PubMed ID: 3680497 [TBL] [Abstract][Full Text] [Related]
17. [Prenatal diagnosis of generalized cytochrome b5 reductase deficiency (congenital methemoglobinemia with mental retardation, type II) (author's transl)]. Kaplan JC; Junien C; Leroux A; Bamberger J; Bakouri S; Boué J; Boué A Ann Med Interne (Paris); 1981; 132(2):93-6. PubMed ID: 7235451 [TBL] [Abstract][Full Text] [Related]
18. Adipose fatty acid composition in a case of generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation. Hirono H Tohoku J Exp Med; 1983 Aug; 140(4):391-4. PubMed ID: 6636138 [TBL] [Abstract][Full Text] [Related]
19. Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia. Manabe J; Arya R; Sumimoto H; Yubisui T; Bellingham AJ; Layton DM; Fukumaki Y Blood; 1996 Oct; 88(8):3208-15. PubMed ID: 8874222 [TBL] [Abstract][Full Text] [Related]